Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia

Annals of Internal Medicine

Volumn 126, Issue 2, 1997, Pages 116-122

  Hinterberger, Wolfgang ^b   Rowlings, Philip A ^a   Hinterberger Fischer, Margareta ^b   Gibson, John ^c   Jacobsen, Niels ^d   Klein, John P ^a   Kolb, Hans Jochem ^e   Stevens, Don A ^f   Horowitz, Mary M ^a   Gale, Robert Peter ^g  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b DANUBE HOSPITAL   (Austria)

^c ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^d Rigshospitalet   (Denmark)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

^g Salick Health Care Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BUSULFAN; CHLORMETHINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; METHOTREXATE;

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; TWINS;

EID: 0031034490     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-2-199701150-00004     Document Type: Article

References (36)

1. Appelbaum FR, Cheever MA, Fefer A, Storb R, Thomas ED. Recurrence of aplastic anemia following cyclophosphamide and syngeneic bone marrow transplantation: evidence for two mechanisms of graft failure. Blood. 1985; 65: 553-6.
2. Hinterberger W, Adolf G, Aichinger G, Dudczak R, Geiß ler K. Hö cker P, et al. Further evidence for lymphokine overproduction in severe aplastic anemia. Blood. 1988; 72: 266-72.
3. Hinterberger W, Adolf G, Bettelheim P, Geissler K. Huber C, Irschick E, et al. Lymphokine overproduction in severe aplastic anemia is not related to blood transfusions. Blood. 1989: 74: 2713-7.
4. Hinterberger W, Geissler K. Fischer M, Kabrna E, Hö cker P. Failure of identical twin bone marrow to restore haemopoiesis in two subjects with severe aplastic anemia without immunosuppressive conditioning. Failure to detect in vitro inhibition of normal donor CFU-GM by patient mononuclear blood cells and bone marrow cells, but impaired capacity of patient MNC to generate colony stimulating factor. Exp Haematol. 1985; 13(Suppl 17): 66-7.
5. Torok-Storb B, Doney K, Brown SL, Prentice RL Correlation of two in vitro tests with clinical response to immunosuppressive therapy in 54 patients with severe aplastic anemia. Blood. 1984; 63: 349-55.
6. Young N. The problem of clonality in aplastic anemia: Dr. Dameshek's riddle, restated. Blood. 1992; 79: 1385-92.
7. Zoumbos NC Gascon P, Djeu Y, Trost SR, Young NS. Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med. 1985; 312: 257-65.
8. Marsh JC, Chang J, Testa NG, Hows JM, Dexter TM. The hematopoietic defect in aplastic anemia assessed by long-term marrow culture. Blood. 1990; 76: 1748-57.
9. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC Gale RP, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood. 1976; 48: 63-70.
10. Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM. Elfenbein GE, Gale RP, et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood. 1989; 73: 606-13.
11. Lu DP. Syngeneic bone marrow transplantation for treatment of aplastic anemia: report of a case and review of the literature. Exp Hematol. 1981; 9: 257-63.
12. Mills SD, Kyle RA. Hallenbeck GA, Pease GL, Cré e IC. Bone marrow transplant in an identical twin. JAMA. 1964; 188: 85-8.
13. Failure of syngeneic bone-marrow graft without preconditioning in post-hepatitis marrow aplasia. Lancet. 1977; 2: 742-4.
14. Lu DP. Syngeneic bone marrow transplantation for treatment of aplastic anaemia: report of a case and review of the literature. Exp Hematol. 1981; 9: 257-63.
15. Glucksberg H, Storb R. Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974; 18: 295-304.
16. Borgan 0, Liestol K. A note on confidence intervals and bands for the survival curve based on transformations. Scandinavian Journal of Statistics. 1990; 17: 35-11.
17. Sullivan KM. Storb R, Buckner CD, Fefer A, Fisher L. Weiden PL. et al. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hé matologie neoplasms. N Engl J Med. 1989; 320: 828-34.
18. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med. 1991; 324: 1297-304.
19. Hinterberger-Fischer M, Hö cker P, Lechner K, Seewann H, Hinterberger W. Oral cyclosporin-A is effective treatment for untreated and also for previously immunosuppressed patients with severe bone marrow failure. Eur J Haematol. 1989,43: 136-42.
20. Appelbaum FR, Fefer A, Cheever MA, Sanders JE, Singer JW, Adamson JW, et al. Treatment of aplastic anemia by bone marrow transplantation in identical twins. Blood. 1980; 55: 1033-8.
21. Gascon P, Zoumbos N, Young N. Analysis of natural killer cells in patients with aplastic anemia. Blood. 1986: 67: 1349-55.
22. Nistico A, Young NS. γ -lmerferon gene expression in the bone marrow of patients with aplastic ané mia. Ann Intern Med. 1994: 120: 463-9.
23. Singer JW. Brown JE. James MC Doney K, Warren RP, Storb R, et al. Effect of peripheral blood lymphocytes from patients with aplastic anemia on granulocytic colony growth from HLA-rnatched and -mismatched marrows: effect of transfusion sensitization. Blood. 1978: 52: 37-46.
24. Singer JW, Doney KC. Thomas ED. Coculture studies of 16 untransfused patients with aplastic anemia. Blood. 1979: 54: 180-4.
25. Zoumbos N, Gascon P, Djeu JY. Young NS. Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo. Proc Natl Acad Sei USA. 1985: 82: 188-92.
26. de Planque MM, Bacigalupo A, Wü rsch A, Hows JM, Devergie A, Frickhofen N, et al. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br J Haematol. 1989: 73: 121-6.
27. de Planque MM, Kluin-Nelemans HC. van Krieken HJ, Kluin PM, Brand A, Beverstock GC, et al. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol. 1988: 70: 55-62.
28. Najean YN, Haguenauer O. Long-teim (5 to 20 years) evolution of nongrafted aplastic anemias. The Cooperative Group for the Study of Aplastic and Refractory Anemias. Blood. 1990: 76: 2222-8.
29. Tkhelli A. Gratwohl A, Wü rsch A, Nissen C Speck B. Ute haematological complications in severe aplastic anemia. Br J Haematol. 1988; 69: 413-9.
30. van Kamp H, Landegent JE, Jansen RP. Willemze R, Fibbe WE. Clonal hematopoiesis in patients with acquired aplastic anemia. Blood. 1991; 78: 3209-14.
31. Gluckman E, Horowitz MM. Champlin RE, Hows JM, Bacigalupo A, Biggs J, et al. Bone marrow transplantation (or severe aplastic anemia: influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood. 1992; 79: 269-75.
32. Gluckman E, Socié G, Devergie A, Bourdeau-Esperou H, Traî neau R, Cosset JM. Bone marrow transplantation in 107 patients with severe aplastic anemia using cyclophosphamide and thoraco-abdominal irradiation for conditioning: long-term follow-up. Blood. 1991; 78: 2451-5.
33. Socié G, Henry-Amar M, Bacigalupo A, Hows J, Tkhelli A, Ljungman P, et al. Malignant tumors occurring after treatment for aplastic anemia. N Engl JMed. 1993; 329: 1152-8.
34. Socié G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood. 1991; 78: 277-9.
35. Wttherspoon RP, Storb R, Pepe M, Longton G, Sullivan KM. Cumulative incidence of secondary solid malignant tumors in aplastic anemia patients given marrow grafts after conditioning with chemotherapy alone [Letter]. Blood. 1992; 79: 289-92.
36. Wolin MJ, Rigor RL. Acute graft-versus-host disease in a recipient of a twin blood cell transplant. Bone Marrow Transplant. 1996; 17: 125-6.